Skip NavigationSkip to Content

Antineoplastic agents 440. Asymmetric synthesis and evaluation of the combretastatin A-1 SAR probes (1S,2S)- and (1R,2R)-1,2-dihydroxy-1-(2 ',3 '-dihydroxy-4 '-methoxyphenyl)-2-(3 '',4 '',5 ''-trimethoxyphenyl)-ethane

  1. Author:
    Pettit, G. R.
    Lippert, J. W.
    Herald, D. L.
    Hamel, E.
    Pettit, R. K.
  2. Author Address

    Pettit GR Arizona State Univ, Canc Res Inst Tempe, AZ 85287 USA Arizona State Univ, Canc Res Inst Tempe, AZ 85287 USA Arizona State Univ, Dept Chem Tempe, AZ 85287 USA NCI, Screening Technol Branch, Dev Therapeut Program,Div Canc Treatment & Diag, Frederick Canc Res & Dev Ctr Frederick, MD 21702 USA
    1. Year: 2000
  1. Journal: Journal of Natural Products
    1. 63
    2. 7
    3. Pages: 969-974
  2. Type of Article: Article
  1. Abstract:

    The synthetic (E)-isomer (3b) of natural combretastatin A-1 (1a) isolated from the African bushwillow Combretum caffrum was the focus of chiral hydroxylation (Sharpless) reactions as part of a structure-activity relationship study. The resulting (R,R)- and (S,S,)-diols (6 and 7) and synthetic intermediates were evaluated against a series of cancer cell lines, microorganisms, and tubulin. Chiral diols 6 and 7 showed increased activity against the P-388 murine lymphocytic leukemia cell Line with ED50 values of 3.9 and 2.9 mu g/mL, respectively, when compared to the precursor (E)-stilbene 3b. In contrast, (E)-stilbene 3b exhibited more potent antibiotic activity than the chiral diols (6 and 7). Both diols, (R,R)-6 and (S,S)7, displayed less cancer cell growth inhibition and less antibiotic activity than did natural combretastatin A-1 (1a) (P-388 ED50 0.25 mu g/mL). [References: 49]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel